Morgan Stanley's big CFR call meets hedging spike
Produced automatically from ORTEX data and published under the ORTEX News editorial standards set by Peter Hillerberg, Editor, ORTEX News. How we publish
Morgan Stanley just made one of the boldest regional bank calls of the year. Analyst Manan Gosalia flipped CFR from Underweight to Overweight and lifted the price target from $141 to $200 — implying 22% upside from Tuesday's close of $163.61. The market's response is more ambivalent.
The upgrade that split opinion
The Morgan Stanley reversal is striking. Moving from the bearish Underweight to Overweight in a single step is unusual. The new $200 target sits well above the analyst consensus mean of $174, suggesting Gosalia is staking out the most bullish position on the street.
Other firms have been inching targets higher since Cullen/Frost's late-July earnings. TD Cowen raised its target to $185. Evercore ISI lifted to $181. Keefe, Bruyette & Woods moved to $175. Cantor Fitzgerald is at $175. None went as far as Morgan Stanley.
The consensus rating stands at buy, and the recent pattern of upward target revisions has been consistent across firms. The Morgan Stanley move accelerates that trend sharply.
Options market pushes back
Investors aren't simply buying the upgrade. The put/call ratio has climbed to 0.31 — the highest level in 20 days. That sits 2.4 standard deviations above the 20-day mean of 0.196.
This is a notable divergence. Analysts are raising targets. The options market is buying more protection.
One reading: some holders are using the post-upgrade lift to add downside hedges rather than add exposure. The stock is up 3.3% on the week but still slightly negative on the month, consolidating near $164 rather than breaking out.
Shorts confirm the directional shift
Short sellers are not fighting the upgrade. SI has fallen 14% over the past week to 5.0% of the free float — a continuation of the trend noted in ORTEX's earlier note from September 2. The prior article flagged a recent peak near 6.3% in mid-August; that unwind is now deeper still.
The borrow market remains relaxed. Availability stands at 640% — more than six shares available for every one currently lent out. Cost to borrow is 0.48%, low and stable.
Institutional context
First Eagle Investment Management added 1.74 million shares as last reported. Baillie Gifford initiated a position of 2.23 million shares. BlackRock added 255,000 shares. These are material moves by long-only institutions building exposure — they sit behind the short-side retreat as a structural tailwind for the stock.
Data summary
- Morgan Stanley upgrade: Underweight → Overweight, PT $141 → $200
- Consensus PT mean: $174; consensus rating: buy
- CFR price: $163.61 (+0.6% Tuesday, +3.3% on week)
- Put/call ratio: 0.31, z-score +2.4 vs 20-day mean of 0.196
- SI % of free float: 5.0%, down 14% week-on-week
- Borrow availability: 640%; cost to borrow: 0.48%
- Next earnings: 29 October 2026
Stocks in this article
See the live data behind this article on ORTEX.
Open CFR on ORTEX →How this article was generated
- Generated
- 9 Sept 2026, 11:07
- Data as of
- 9 Sept 2026, 11:00
- Prompt version
- v1.0
- Data sources
- Short interestCost to borrowUtilizationOptions flowEarningsAnalyst consensusInstitutional positioningORTEX Alpha signalsRecent ORTEX notesPrevious Mi Articles
ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.